• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9介导的CXCR4和CXCR7基因敲除对三阴性乳腺癌细胞功能的影响

Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells.

作者信息

Yang Meng, Zeng Chen, Li Peiting, Qian Liyuan, Ding Boni, Huang Lihua, Li Gang, Jiang Han, Gong Ni, Wu Wei

机构信息

Department of Breast Thyroid Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, People's Republic of China,

Central Laboratory, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, People's Republic of China.

出版信息

Onco Targets Ther. 2019 May 17;12:3849-3858. doi: 10.2147/OTT.S195661. eCollection 2019.

DOI:10.2147/OTT.S195661
PMID:31190884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6527053/
Abstract

BACKGROUND

Breast cancer is one of the most common malignancies threatening women's health. Triple-negative breast cancer (TNBC) is a special type of breast cancer with high invasion and metastasis. CXCL12 and its receptors CXCR4 and CXCR7 play a crucial role in the progress of breast cancer. The aim of this study was to investigate the effect of CXCR4 and CXCR7 on the function of TNBC.

MATERIALS AND METHODS

We used the CRISPR/Cas9 technique to carry out a single knockout of the CXCR4 or CXCR7 gene and co-knockout of CXCR4 and CXCR7 genes in the TNBC cell line (MDA-MB-231). The single knockout and co-knockout cells were screened and verified by PCR sequencing and Western blot assay, the effect of single knockout and co-knockout on the proliferation of TNBC cells was examined using the Cell Counting Kit-8 and colony formation assays, the migration and invasion of TNBC cells were examined by the transwell and wound-healing assays, the changes in the cell cycle distribution after knockout were detected by flow cytometry, and the difference in the migration and invasion of single knockout and co-knockout induced by CXCL12 was observed by adding CXCL12 in the experimental group.

RESULTS

The single knockout of the CXCR4 or CXCR7 gene significantly reduced the cell proliferation, growth, migration, and invasion and delayed the conversion of the G1/S cycle, while the co-knockout inhibited these biological abilities more significantly. In both the knockout and control groups, the migration and invasion of CXCL12-added cells were significantly stronger than those of the non-CXCL12-added cells, and CXCL12 induced lesser migration and invasion in the CXCR4 and CXCR7 co-knockout group than in the single knockout groups.

CONCLUSION

The knockout of the CXCR4 and CXCR7 genes affects the binding capacity and functions of CXCL12, inhibits the malignant progression of TNBC cells significantly, and may become a potential target for the treatment of TNBC.

摘要

背景

乳腺癌是威胁女性健康的最常见恶性肿瘤之一。三阴性乳腺癌(TNBC)是一种具有高侵袭和转移能力的特殊类型乳腺癌。CXCL12及其受体CXCR4和CXCR7在乳腺癌进展中起关键作用。本研究旨在探讨CXCR4和CXCR7对TNBC功能的影响。

材料与方法

我们使用CRISPR/Cas9技术在TNBC细胞系(MDA-MB-231)中对CXCR4或CXCR7基因进行单敲除以及对CXCR4和CXCR7基因进行共敲除。通过PCR测序和蛋白质印迹分析对单敲除和共敲除细胞进行筛选和验证,使用细胞计数试剂盒-8和集落形成试验检测单敲除和共敲除对TNBC细胞增殖的影响,通过Transwell和伤口愈合试验检测TNBC细胞的迁移和侵袭能力,通过流式细胞术检测敲除后细胞周期分布的变化,并在实验组中添加CXCL12观察单敲除和共敲除诱导的迁移和侵袭差异。

结果

CXCR4或CXCR7基因的单敲除显著降低了细胞增殖、生长、迁移和侵袭能力,并延迟了G1/S周期转换,而共敲除对这些生物学能力的抑制作用更显著。在敲除组和对照组中,添加CXCL12的细胞的迁移和侵袭能力均明显强于未添加CXCL12的细胞,并且CXCL12在CXCR4和CXCR7共敲除组中诱导的迁移和侵袭比在单敲除组中更小。

结论

CXCR4和CXCR7基因的敲除影响CXCL12的结合能力和功能,显著抑制TNBC细胞的恶性进展,可能成为TNBC治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/f760a51d6193/ott-12-3849Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/865eddf076a5/ott-12-3849Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/d86ecf2dde74/ott-12-3849Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/bd473f683a40/ott-12-3849Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/f760a51d6193/ott-12-3849Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/865eddf076a5/ott-12-3849Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/d86ecf2dde74/ott-12-3849Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/bd473f683a40/ott-12-3849Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dea/6527053/f760a51d6193/ott-12-3849Fig4.jpg

相似文献

1
Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells.CRISPR/Cas9介导的CXCR4和CXCR7基因敲除对三阴性乳腺癌细胞功能的影响
Onco Targets Ther. 2019 May 17;12:3849-3858. doi: 10.2147/OTT.S195661. eCollection 2019.
2
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.趋化因子 CXCL12 被 CXCR7 清除可促进 CXCR4 阳性乳腺癌细胞的肿瘤生长和转移。
Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.
3
Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7.滋养层细胞分泌的 CXCL12 对人早孕蜕膜上皮细胞迁移和侵袭的调节作用是通过 CXCR4 而不是 CXCR7 介导的。
Reprod Biol Endocrinol. 2018 Mar 2;16(1):17. doi: 10.1186/s12958-018-0333-2.
4
Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.炎症性CXCL12 - CXCR4/CXCR7轴介导G蛋白信号通路,影响鼻咽癌细胞的侵袭和迁移。
Tumour Biol. 2016 Jun;37(6):8169-79. doi: 10.1007/s13277-015-4686-2. Epub 2015 Dec 29.
5
Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.趋化因子受体 4 和 7 在乳腺癌转移中的相反作用。
Breast Cancer Res. 2011;13(6):R128. doi: 10.1186/bcr3074. Epub 2011 Dec 9.
6
[Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].趋化因子CXCL12及其受体(CXCR4和CXCR7)在人乳腺癌不同分子亚型中的表达及临床意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Feb 28;42(2):147-153. doi: 10.11817/j.issn.1672-7347.2017.02.005.
7
CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.CXCL12-CXCR4/CXCR7轴有助于口腔鳞状细胞癌的细胞运动。
Tumour Biol. 2016 Jan;37(1):567-75. doi: 10.1007/s13277-015-3803-6. Epub 2015 Aug 2.
8
Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.雄激素受体与趋化因子受体4和7形成一个信号轴,以调节依赖于CXCL12的细胞运动。
BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.
9
Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4.柴胡皂苷A通过下调CXCR4抑制三阴性乳腺癌的生长和转移。
Front Oncol. 2020 Jan 28;9:1487. doi: 10.3389/fonc.2019.01487. eCollection 2019.
10
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.CXCL12、CXCR4和CXCR7在乳腺癌患者中的预后意义。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13217-24. eCollection 2015.

引用本文的文献

1
Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells.使用嵌合抗原受体自然杀伤细胞(CAR NK细胞)克服肿瘤免疫治疗耐药性的新策略。
Front Immunol. 2025 May 29;16:1550652. doi: 10.3389/fimmu.2025.1550652. eCollection 2025.
2
Connexin 43 hemichannels and related diseases.连接蛋白43半通道与相关疾病
Antib Ther. 2024 Nov 11;7(4):361-369. doi: 10.1093/abt/tbae024. eCollection 2024 Oct.
3
From Biosensors to Robotics: Pioneering Advances in Breast Cancer Management.从生物传感器到机器人:乳腺癌管理的开创性进展。

本文引用的文献

1
[Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].趋化因子CXCL12及其受体(CXCR4和CXCR7)在人乳腺癌不同分子亚型中的表达及临床意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Feb 28;42(2):147-153. doi: 10.11817/j.issn.1672-7347.2017.02.005.
2
Telomere Length and Breast Cancer Prognosis: A Systematic Review.端粒长度与乳腺癌预后:一项系统综述。
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):3-10. doi: 10.1158/1055-9965.EPI-16-0343. Epub 2016 Sep 27.
3
miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7.
Sensors (Basel). 2024 Sep 23;24(18):6149. doi: 10.3390/s24186149.
4
CRISPR/Cas9 systems: Delivery technologies and biomedical applications.CRISPR/Cas9系统:递送技术与生物医学应用
Asian J Pharm Sci. 2023 Nov;18(6):100854. doi: 10.1016/j.ajps.2023.100854. Epub 2023 Oct 21.
5
CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer.基于 CRISPR 的基因编辑:癌症研究和治疗的现代方法。
Appl Biochem Biotechnol. 2024 Jul;196(7):4439-4456. doi: 10.1007/s12010-023-04708-2. Epub 2023 Sep 22.
6
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics.CRISPR/Cas9作为三阴性乳腺癌的治疗工具:从实验台到临床应用
Front Mol Biosci. 2023 Jul 4;10:1214489. doi: 10.3389/fmolb.2023.1214489. eCollection 2023.
7
The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies.微小RNA在乳腺癌血管生成中的多种作用,特别关注基于微小RNA的新型递送策略。
Cancer Cell Int. 2023 Feb 10;23(1):24. doi: 10.1186/s12935-022-02837-y.
8
Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement.纳米材料辅助的CRISPR基因工程——三阴性乳腺癌治疗进展的一个标志。
Mater Today Bio. 2022 Oct 4;16:100450. doi: 10.1016/j.mtbio.2022.100450. eCollection 2022 Dec.
9
CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment.CRISPR/Cas9:一种革命性的基因组编辑工具,可用于人类癌症治疗。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221132078. doi: 10.1177/15330338221132078.
10
Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.CRISPR/Cas9 介导的基因组编辑和肿瘤细胞内靶向的最新进展:癌症管理的创新策略。
Cancer Commun (Lond). 2022 Dec;42(12):1257-1287. doi: 10.1002/cac2.12366. Epub 2022 Oct 9.
miR-100 通过靶向 CXCR7 抑制食管鳞癌细胞的增殖和肿瘤生长。
Oncol Rep. 2016 Jun;35(6):3453-9. doi: 10.3892/or.2016.4701. Epub 2016 Mar 23.
4
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.CXCL12、CXCR4和CXCR7在乳腺癌患者中的预后意义。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13217-24. eCollection 2015.
5
GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.GLI1 协调 CXCR4/CXCR7 信号传导以增强乳腺癌细胞的迁移和转移。
Oncotarget. 2015 Oct 20;6(32):33648-57. doi: 10.18632/oncotarget.5203.
6
Induction of Regulatory B-Cells by Mesenchymal Stem Cells is Affected by SDF-1α-CXCR7.间充质干细胞对调节性B细胞的诱导受SDF-1α-CXCR7的影响。
Cell Physiol Biochem. 2015;37(1):117-30. doi: 10.1159/000430338. Epub 2015 Aug 17.
7
CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo.CXCL12趋化因子表达在体外和体内均可抑制人类乳腺癌的生长和转移。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6671-8. eCollection 2014.
8
Breast cancer histopathology image analysis: a review.乳腺癌组织病理学图像分析:综述
IEEE Trans Biomed Eng. 2014 May;61(5):1400-11. doi: 10.1109/TBME.2014.2303852.
9
Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.在甲状腺癌体内模型中,核因子κB依赖的血管生成调节及转移与分泌的白细胞介素-8相关。
J Clin Endocrinol Metab. 2014 Aug;99(8):E1436-44. doi: 10.1210/jc.2013-3636. Epub 2014 Apr 23.
10
Genome-scale CRISPR-Cas9 knockout screening in human cells.全基因组规模的 CRISPR-Cas9 基因敲除筛选在人类细胞中的应用。
Science. 2014 Jan 3;343(6166):84-87. doi: 10.1126/science.1247005. Epub 2013 Dec 12.